{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:17:46Z","timestamp":1759421866920,"version":"3.41.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.phrs.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T17:26:19Z","timestamp":1534526779000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeted drugs in spondyloarthritis during pregnancy and lactation"],"prefix":"10.1016","volume":"136","author":[{"given":"Miguel A.","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Romo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-5572","authenticated-orcid":false,"given":"Sergio R.","family":"Guti\u00e9rrez-Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafhne","family":"Miranda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4237-8338","authenticated-orcid":false,"given":"Lilia I.","family":"Hern\u00e1ndez-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.","family":"Jara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.08.009_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.37829","article-title":"Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?","volume":"65","author":"Baeten","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.08.009_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.phrs.2018.08.009_bib0015","first-page":"120","article-title":"Ankylosing spondylitis -the female aspect","volume":"25","author":"Ostensen","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00296-014-3135-7","article-title":"Musculoskeletal problems in pregnancy","volume":"35","author":"Thabah","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2018.08.009_bib0030","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3899\/jrheum.101174","article-title":"Effect of pregnancy on ankylosing spondylitis: a case-control study","volume":"38","author":"Lui","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0035","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3109\/14767058.2015.1089432","article-title":"Pregnancy outcome in patients with ankylosing spondylitis","volume":"29","author":"Timur","year":"2016","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.phrs.2018.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/ard.2003.016881","article-title":"A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments","volume":"63","author":"\u00d8stensen","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0045","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/annrheumdis-2015-207992","article-title":"Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study","volume":"75","author":"Jakobsson","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0050","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.30210","article-title":"Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth","volume":"63","author":"Wallenius","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.08.009_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/j.1600-0412.2000.079006490.x","article-title":"Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway","volume":"79","author":"Skomsvoll","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.phrs.2018.08.009_bib0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1573397113666170317114857","article-title":"Ankylosing spondylitis and pregnancy: a literature review","volume":"13","author":"Giovannopoulou","year":"2017","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.phrs.2018.08.009_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0897.1992.tb00801.x","article-title":"The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis","volume":"28","author":"Ostensen","year":"1992","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3899\/jrheum.160929","article-title":"Pregnancy outcomes in patients with psoriatic arthritis","volume":"44","author":"Mouyis","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","article-title":"Psoriatic arthritis disease activity during pregnancy and the first-year postpartum","volume":"46","author":"Polachek","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.08.009_bib0080","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s10620-015-3677-x","article-title":"Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a Meta-Analysis","volume":"60","author":"O\u2019Toole","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2018.08.009_bib0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jp.2014.41","article-title":"Association between maternal inflammatory bowel disease and adverse perinatal outcomes","volume":"34","author":"Getahun","year":"2014","journal-title":"Perinatology"},{"key":"10.1016\/j.phrs.2018.08.009_bib0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/aji.12289","article-title":"Understanding the complexity of the immune system during pregnancy","volume":"72","author":"Racicot","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri.2017.54","article-title":"Unique aspects of the perinatal immune system","volume":"17","author":"Zhang","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijoa.2015.12.005","article-title":"Cytokines in the perinatal period - Part I","volume":"26","author":"Chau","year":"2016","journal-title":"Int. J. Obstet. Anesth."},{"key":"10.1016\/j.phrs.2018.08.009_bib0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/labinvest.2015.159","article-title":"TNF-\u03b1 alters the inflammatory secretion profile of human first trimester placenta","volume":"96","author":"Siwetz","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phrs.2018.08.009_bib0115","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3748\/wjg.v19.i17.2591","article-title":"Tumor necrosis factor-\u03b1 inhibitor therapy and fetal risk: a systematic literature review","volume":"19","author":"Marchioni","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aji.12447","article-title":"Association between serum TNF-\u03b1 levels and recurrent spontaneous miscarriage: a meta-analysis","volume":"75","author":"Zhang","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/aji.12417","article-title":"Placental regulation of inflammation and hypoxia after TNF-\u03b1 infusion in mice","volume":"74","author":"Bobek","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2018.08.009_bib0130","first-page":"1","article-title":"Evaluation of maternal serum hypoxia inducible factor-1\u03b1, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia","author":"Alici Davuto\u011flu","year":"2017","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.phrs.2018.08.009_bib0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-017-1269-1","article-title":"Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients","volume":"19","author":"van den Brandt","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2018.08.009_bib0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrrheum.2016.42","article-title":"New evidence on the management of spondyloarthritis","volume":"12","author":"Sieper","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"year":"2018","series-title":"FDA Pregnancy Risk Information: An Update","key":"10.1016\/j.phrs.2018.08.009_bib0145"},{"key":"10.1016\/j.phrs.2018.08.009_bib0150","first-page":"4","article-title":"Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women","volume":"4","author":"Stone","year":"2014","journal-title":"J. Clin. Toxicol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0155","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","article-title":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis","volume":"76","author":"Komaki","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2018.08.009_bib0165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/pds.4261","article-title":"Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use","volume":"26","author":"Carman","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.phrs.2018.08.009_bib0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2016-209322","article-title":"Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis","volume":"76","author":"Burmester","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jri.2016.04.284","article-title":"Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer","volume":"116","author":"Porter","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0180","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.1640","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","author":"Mariette","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"March","key":"10.1016\/j.phrs.2018.08.009_bib0185","doi-asserted-by":"crossref","first-page":"j895","DOI":"10.1136\/bmj.j895","article-title":"Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study","volume":"356","author":"Desai","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2018.08.009_bib0190","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0195","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/rheumatology\/kev405","article-title":"BSR and BHPR Standards, Guidelines and Audit Working Group, BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology Oxford (Oxford)"},{"key":"10.1016\/j.phrs.2018.08.009_bib0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IJWH.S6029","article-title":"The use of anti-TNF\u03b1 medications for rheumatologic disease in pregnancy","volume":"2","author":"Clowse","year":"2010","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.phrs.2018.08.009_bib0205","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann. Rheum. Dis."},{"author":"CIMZIA\u00ae (certolizumab pegol)","key":"10.1016\/j.phrs.2018.08.009_bib0210"},{"key":"10.1016\/j.phrs.2018.08.009_bib0215","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0220","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s10620-015-3992-2","article-title":"The effect of maternal peripartum anti-TNF\u03b1 use on infant immune response","volume":"61","author":"Sheibani","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2018.08.009_bib0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.08.009_bib0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.MIB.0000440984.86659.4f","article-title":"Impact of antitumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children","volume":"20","author":"Bortlik","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2018.08.009_bib0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2016.1115351","article-title":"Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy","volume":"15","author":"Ling","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.phrs.2018.08.009_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12560","article-title":"Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s","volume":"62","author":"Matsuzaki","year":"2018","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.placenta.2006.01.016","article-title":"Interleukin-17 expression in the human placenta","volume":"28","author":"Pongcharoen","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.phrs.2018.08.009_bib0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jri.2009.09.005","article-title":"A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour","volume":"84","author":"Ito","year":"2010","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/icb.2016.48","article-title":"The majority of murine \u03b3\u03b4 T cells at the maternal-fetal interface in pregnancy produce IL-17","volume":"94","author":"Pinget","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0260","doi-asserted-by":"crossref","first-page":"6904325","DOI":"10.1155\/2017\/6904325","article-title":"The role of interleukin-17, interleukin-23, and transforming growth factor-\u03b2 in pregnancy complicated by placental insufficiency","volume":"2017","author":"Darmochwal-Kolarz","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.phrs.2018.08.009_bib0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2017.04.010","article-title":"Maternal IL-17A in autism","volume":"229","author":"Wong","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0270","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","article-title":"Th17 cells and IL-17 a\u2013focus on immunopathogenesis and immunotherapeutics","volume":"43","author":"Van den Berg","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.08.009_bib0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/BOR.0000000000000147","article-title":"Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis","volume":"27","author":"Mease","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/ada.2016.61599","article-title":"Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases","volume":"33","author":"Wasilewska","year":"2016","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2217\/imt-2017-0077","article-title":"A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis","volume":"9","author":"Roostaeyan","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.phrs.2018.08.009_bib0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.reprotox.2015.10.008","article-title":"Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys","volume":"58","author":"Clarke","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"May","key":"10.1016\/j.phrs.2018.08.009_bib0295","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding, the Australasian Psoriasis Collaboration","author":"Rademaker","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0300","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cytogfr.2015.07.005","article-title":"Insights into IL-23 biology: from structure to function","volume":"26","author":"Floss","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2018.08.009_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/030.63.2016.1.1","article-title":"IL-12 family cytokines: general characteristics, pathogenic microorganisms, receptors, and signalling pathways","volume":"63","author":"Behzadi","year":"2016","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"10.1016\/j.phrs.2018.08.009_bib0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0897.2009.00771.x","article-title":"Circulating and decidual Th17 cell levels in healthy pregnancy","volume":"63","author":"Nakashima","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jri.2010.06.154","article-title":"Expression and role of interleukin-23 in human endometrium throughout the menstrual cycle and early pregnancy","volume":"87","author":"Uz","year":"2010","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2015.11.118","article-title":"Interleukin-23 regulates the functions of human decidual immune cells during early pregnancy","volume":"469","author":"Cai","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2018.08.009_bib0325","doi-asserted-by":"crossref","first-page":"606459","DOI":"10.1155\/2012\/606459","article-title":"Follicular proinflammatory cytokines and chemokines as markers of IVF success","volume":"2012","author":"Sarapik","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0330","doi-asserted-by":"crossref","first-page":"e0163252","DOI":"10.1371\/journal.pone.0163252","article-title":"Differences in cytokine expression and STAT3 activation between healthy controls and patients of unexplained recurrent spontaneous abortion (URSA) during early pregnancy","volume":"11","author":"Cai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.08.009_bib0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-0897.2007.00501.x","article-title":"Polymorphisms in the interleukin-12\/18 genes and recurrent spontaneous abortion","volume":"58","author":"Ostoji\u0107","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0340","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/bdrb.20287","article-title":"Developmental and reproductive toxicology studies in IL-12p40 knockout mice","volume":"92","author":"Enright","year":"2011","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0345","first-page":"681","article-title":"Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression","volume":"35","author":"Druyts","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdrb.20250","article-title":"Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12\/23p40 monoclonal antibody, during pregnancy and lactation","volume":"89","author":"Martin","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12214","article-title":"Pregnancy outcomes of two patients exponed to ustekinumab in the first trimester","volume":"55","author":"Sheeran","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0360","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jdv.12872","article-title":"Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis","volume":"30","author":"Alsenaid","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000380880","article-title":"Pregnancy during ustekinumab treatment for severe psoriasis","volume":"231","author":"Rocha","year":"2015","journal-title":"Dermatology."},{"key":"10.1016\/j.phrs.2018.08.009_bib0370","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/jdv.13499","article-title":"Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn\u2019s disease and paradoxical psoriasis","volume":"30","author":"Galli-Novak","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jcpt.12492","article-title":"Ustekinumab therapy for Crohn\u2019s disease during pregnancy: a case report and review of the literature","volume":"42","author":"Cortes","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.phrs.2018.08.009_bib0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12876-017-0633-6","article-title":"Fetal death in utero and miscarriage in a patient with Crohn\u2019s disease under therapy with ustekinumab: case-report and review of the literature","volume":"17","author":"Venturin","year":"2017","journal-title":"BMC Gastroenterol."},{"issue":"October","key":"10.1016\/j.phrs.2018.08.009_bib0385","article-title":"Ustekinumab drug levels in maternal and cord blood in a woman with Crohn\u2019s disease treated until 33 weeks gestation","author":"Rowan","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.phrs.2018.08.009_bib0390","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.autrev.2016.07.014","article-title":"Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancyand lactation","volume":"15","author":"Levy","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2018.08.009_bib0395","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2014.06.013","article-title":"The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus","volume":"162","author":"Rocca","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.phrs.2018.08.009_bib0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0897.2010.00893.x","article-title":"IL-17 increased in the third trimester in healthy women with term labor","volume":"65","author":"Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0410","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12657","article-title":"The transdifferentiation of regulatory T and Th17 cells in autoimmune\/inflammatory diseases and its potential implications in pregnancy complications","volume":"78","author":"Liu","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2018.08.009_bib0415","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"Mease","year":"2017","journal-title":"Ann. Rheum. Dis."},{"year":"2018","series-title":"Product Information. Orencia (abatacept)","key":"10.1016\/j.phrs.2018.08.009_bib0420"},{"key":"10.1016\/j.phrs.2018.08.009_bib0425","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2015.06.016","article-title":"Pregnancy outcomes following exposure to abatacept during pregnancy","volume":"45","author":"Kumar","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.08.009_bib0430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.reuma.2014.12.004","article-title":"Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part II","volume":"11","author":"Saavedra Salinas","year":"2015","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.phrs.2018.08.009_bib0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2018.08.009_bib0440","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1615977","article-title":"Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors","volume":"377","author":"Gladman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2018.08.009_bib0445","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or adalimumab versus placebo for psoriatic arthritis","volume":"377","author":"Mease","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2018.08.009_bib0450","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/17512433.2017.1305268","article-title":"The use of biologics in pregnant patients with rheumatic disease","volume":"10","author":"\u00d8stensen","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"year":"2018","series-title":"Product Information. Xeljanz (tofacitinib)","key":"10.1016\/j.phrs.2018.08.009_bib0455"},{"key":"10.1016\/j.phrs.2018.08.009_bib0460","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40264-016-0431-z","article-title":"Pregnancy outcomes in the tofacitinib safety databases for rheumatoid arthritis and psoriasis","volume":"39","author":"Clowse","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.phrs.2018.08.009_bib0465","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1080\/14656566.2017.1378343","article-title":"Small molecule therapy for managing moderate to severe psoriatic arthritis","volume":"18","author":"Costa","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.phrs.2018.08.009_bib0470","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal."},{"year":"2018","series-title":"Product Information. Otezla (apremilast)","key":"10.1016\/j.phrs.2018.08.009_bib0475"},{"key":"10.1016\/j.phrs.2018.08.009_bib0480","doi-asserted-by":"crossref","first-page":"A437","DOI":"10.1016\/j.autrev.2011.11.013","article-title":"Interaction of pregnancy and autoimmune rheumatic disease","volume":"11","author":"\u00d8stensen","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2018.08.009_bib0485","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12948-015-0015-y","article-title":"T helper cell mediated-tolerance towards fetal allograft in successful pregnancy","volume":"13","author":"Piccinni","year":"2015","journal-title":"Clin. Mol. Allergy"},{"key":"10.1016\/j.phrs.2018.08.009_bib0490","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phrs.2017.02.005","article-title":"Guidelines for preparing color figures for everyone including the colorblind","volume":"119","author":"Roskoski","year":"2017","journal-title":"Pharmacol. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818305024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818305024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T11:42:29Z","timestamp":1751802149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818305024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":98,"alternative-id":["S1043661818305024"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.08.009","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted drugs in spondyloarthritis during pregnancy and lactation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}